Literature DB >> 23839893

A successful case in cancer pain management with high-dose intravenous morphine.

T Ishikawa1, K Hiraga.   

Abstract

Entities:  

Year:  1995        PMID: 23839893     DOI: 10.1007/BF02479958

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  10 in total

1.  Treatment of cancer pain of the head and neck by continuous intravenous infusion of high-dose morphine: report of two cases.

Authors:  Y Hashimoto; M Takarada; H Tanioka; B M Rigor
Journal:  J Oral Maxillofac Surg       Date:  1990-04       Impact factor: 1.895

2.  Japan: status of cancer pain and palliative care.

Authors:  F Takeda
Journal:  J Pain Symptom Manage       Date:  1993-08       Impact factor: 3.612

3.  A single case study using high-dose hydromorphone to control severe pain and serial psychometric testing to assess effects.

Authors:  H Hays; P Mayo
Journal:  J Pain Symptom Manage       Date:  1993-04       Impact factor: 3.612

4.  Clinical experience of long-term treatment with epidural and intrathecal opioids--a nationwide survey.

Authors:  S Arnér; N Rawal; L L Gustafsson
Journal:  Acta Anaesthesiol Scand       Date:  1988-04       Impact factor: 2.105

5.  Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.

Authors:  Gong Qian-Ling; Jan Hedner; Roland Björkman; Thomas Hedner
Journal:  Pain       Date:  1992-02       Impact factor: 6.961

6.  Morphine-3-glucuronide--a potent antagonist of morphine analgesia.

Authors:  M T Smith; J A Watt; T Cramond
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

7.  Paradoxical pain.

Authors:  D Bowsher
Journal:  BMJ       Date:  1993-02-20

8.  Relationship between plasma concentration of morphine and analgesic effectiveness.

Authors:  N Yokokawa; K Hiraga; T Oguma; M Konishi
Journal:  Postgrad Med J       Date:  1991       Impact factor: 2.401

9.  The incidence of cancer pain and improvement of pain management in Japan.

Authors:  K Hiraga; T Mizuguchi; F Takeda
Journal:  Postgrad Med J       Date:  1991       Impact factor: 2.401

10.  Subcutaneous lidocaine for treatment of neuropathic cancer pain.

Authors:  William G Brose; Micheal J Cousins
Journal:  Pain       Date:  1991-05       Impact factor: 6.961

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.